Statistics

Total Visits

Views
Bevacizumab plus capecitabine and oxaliplatin (XELOX) as first-line treatment for elderly patients with metastatic colorectal cancer (mCRC) suitable for combination chemotherapy: Efficacy and safety findings from the phase II BECOX study (GEMCAD Study Gro99

Select a period of time:

Number of views in the range

Views
Bevacizumab plus capecitabine and oxaliplatin (XELOX) as first-line treatment for elderly patients with metastatic colorectal cancer (mCRC) suitable for combination chemotherapy: Efficacy and safety findings from the phase II BECOX study (GEMCAD Study Gro40

Views

Views
December 20254
January 20262
February 20261
March 20263
April 20267
May 202613
June 202610
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States14
Netherlands8
Mexico3
United Kingdom3
Spain2
Ethiopia2
Argentina2
Germany1
France1
Italy1
 

Top cities views

Views
Groningen7
Santa Clara2
Addis Ababa2
Amsterdam1
Berazategui1
Cagliari1
Fremont1
Guadalajara1
Istanbul1
Iztapalapa1